Efficacy of treatments for infantile spasms: A systematic review

Ji Min Song, Jongsung Hahn, Se Hee Kim, Min Jung Chang

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Objectives:West syndrome (also known as infantile spasm because of its main seizure type) is a rare form of epilepsy that begins during early infancy. Recent guidelines and reviews on West syndrome recommend the use of adrenocorticotropic hormone steroids, or vigabatrin, as the firstline treatment. However, West syndrome remains to be one of the most challenging epilepsies to treat. Here, we systematically reviewed the current literature obtained during the previous decade. This article provides an overview of the current treatment of infantile spasms. Methods: PubMed and EMBASE were searched to retrieve studies on human published during 2005-2015 and to identify patients with clinical diagnosis of infantile spasms. Drug or diet treatments were used as interventions and comparators. Results: We included 55 studies, of which 1 study was a meta-analysis, 9 were randomized controlled trials, 21 were prospective studies, and 24 were retrospective studies. Topiramate, levetiracetam, zonisamide, and sodium valproate with benzodiazepine (clonazepam or nitrazepam) were found to be potential drugs for treatingWest syndrome besides adrenocorticotropic hormone, steroids, and vigabatrin. Ketogenic diet and modified Atkins diet were also found to be effective. Conclusions: To date, data regarding the efficacy of treatments of West syndrome still remain limited. Some treatments, including topiramate and ketogenic diet, seem promising besides adrenocorticotropic hormone, steroids, and vigabatrin.Well-designed trials are warranted to validate the findings.

Original languageEnglish
Pages (from-to)63-84
Number of pages22
JournalClinical Neuropharmacology
Volume40
Issue number2
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Infantile Spasms
Vigabatrin
Ketogenic Diet
Adrenocorticotropic Hormone
etiracetam
zonisamide
Steroids
Epilepsy
Nitrazepam
Carbohydrate-Restricted Diet
Clonazepam
Valproic Acid
Therapeutics
Benzodiazepines
PubMed
Pharmaceutical Preparations
Meta-Analysis
Seizures
Randomized Controlled Trials
Retrospective Studies

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Song, Ji Min ; Hahn, Jongsung ; Kim, Se Hee ; Chang, Min Jung. / Efficacy of treatments for infantile spasms : A systematic review. In: Clinical Neuropharmacology. 2017 ; Vol. 40, No. 2. pp. 63-84.
@article{31571cf2678f437fb89f3577540f9712,
title = "Efficacy of treatments for infantile spasms: A systematic review",
abstract = "Objectives:West syndrome (also known as infantile spasm because of its main seizure type) is a rare form of epilepsy that begins during early infancy. Recent guidelines and reviews on West syndrome recommend the use of adrenocorticotropic hormone steroids, or vigabatrin, as the firstline treatment. However, West syndrome remains to be one of the most challenging epilepsies to treat. Here, we systematically reviewed the current literature obtained during the previous decade. This article provides an overview of the current treatment of infantile spasms. Methods: PubMed and EMBASE were searched to retrieve studies on human published during 2005-2015 and to identify patients with clinical diagnosis of infantile spasms. Drug or diet treatments were used as interventions and comparators. Results: We included 55 studies, of which 1 study was a meta-analysis, 9 were randomized controlled trials, 21 were prospective studies, and 24 were retrospective studies. Topiramate, levetiracetam, zonisamide, and sodium valproate with benzodiazepine (clonazepam or nitrazepam) were found to be potential drugs for treatingWest syndrome besides adrenocorticotropic hormone, steroids, and vigabatrin. Ketogenic diet and modified Atkins diet were also found to be effective. Conclusions: To date, data regarding the efficacy of treatments of West syndrome still remain limited. Some treatments, including topiramate and ketogenic diet, seem promising besides adrenocorticotropic hormone, steroids, and vigabatrin.Well-designed trials are warranted to validate the findings.",
author = "Song, {Ji Min} and Jongsung Hahn and Kim, {Se Hee} and Chang, {Min Jung}",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/WNF.0000000000000200",
language = "English",
volume = "40",
pages = "63--84",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Efficacy of treatments for infantile spasms : A systematic review. / Song, Ji Min; Hahn, Jongsung; Kim, Se Hee; Chang, Min Jung.

In: Clinical Neuropharmacology, Vol. 40, No. 2, 01.01.2017, p. 63-84.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Efficacy of treatments for infantile spasms

T2 - A systematic review

AU - Song, Ji Min

AU - Hahn, Jongsung

AU - Kim, Se Hee

AU - Chang, Min Jung

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objectives:West syndrome (also known as infantile spasm because of its main seizure type) is a rare form of epilepsy that begins during early infancy. Recent guidelines and reviews on West syndrome recommend the use of adrenocorticotropic hormone steroids, or vigabatrin, as the firstline treatment. However, West syndrome remains to be one of the most challenging epilepsies to treat. Here, we systematically reviewed the current literature obtained during the previous decade. This article provides an overview of the current treatment of infantile spasms. Methods: PubMed and EMBASE were searched to retrieve studies on human published during 2005-2015 and to identify patients with clinical diagnosis of infantile spasms. Drug or diet treatments were used as interventions and comparators. Results: We included 55 studies, of which 1 study was a meta-analysis, 9 were randomized controlled trials, 21 were prospective studies, and 24 were retrospective studies. Topiramate, levetiracetam, zonisamide, and sodium valproate with benzodiazepine (clonazepam or nitrazepam) were found to be potential drugs for treatingWest syndrome besides adrenocorticotropic hormone, steroids, and vigabatrin. Ketogenic diet and modified Atkins diet were also found to be effective. Conclusions: To date, data regarding the efficacy of treatments of West syndrome still remain limited. Some treatments, including topiramate and ketogenic diet, seem promising besides adrenocorticotropic hormone, steroids, and vigabatrin.Well-designed trials are warranted to validate the findings.

AB - Objectives:West syndrome (also known as infantile spasm because of its main seizure type) is a rare form of epilepsy that begins during early infancy. Recent guidelines and reviews on West syndrome recommend the use of adrenocorticotropic hormone steroids, or vigabatrin, as the firstline treatment. However, West syndrome remains to be one of the most challenging epilepsies to treat. Here, we systematically reviewed the current literature obtained during the previous decade. This article provides an overview of the current treatment of infantile spasms. Methods: PubMed and EMBASE were searched to retrieve studies on human published during 2005-2015 and to identify patients with clinical diagnosis of infantile spasms. Drug or diet treatments were used as interventions and comparators. Results: We included 55 studies, of which 1 study was a meta-analysis, 9 were randomized controlled trials, 21 were prospective studies, and 24 were retrospective studies. Topiramate, levetiracetam, zonisamide, and sodium valproate with benzodiazepine (clonazepam or nitrazepam) were found to be potential drugs for treatingWest syndrome besides adrenocorticotropic hormone, steroids, and vigabatrin. Ketogenic diet and modified Atkins diet were also found to be effective. Conclusions: To date, data regarding the efficacy of treatments of West syndrome still remain limited. Some treatments, including topiramate and ketogenic diet, seem promising besides adrenocorticotropic hormone, steroids, and vigabatrin.Well-designed trials are warranted to validate the findings.

UR - http://www.scopus.com/inward/record.url?scp=85016402831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016402831&partnerID=8YFLogxK

U2 - 10.1097/WNF.0000000000000200

DO - 10.1097/WNF.0000000000000200

M3 - Review article

C2 - 28288483

AN - SCOPUS:85016402831

VL - 40

SP - 63

EP - 84

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 2

ER -